Thrombolysis in Stroke With Unknown Onset Based on Non-Contrast Computerized Tomography (TRUST CT).
Adult
Aged
Aged, 80 and over
Feasibility Studies
Female
Humans
Incidence
Intracranial Hemorrhages
/ epidemiology
Magnetic Resonance Imaging
Male
Middle Aged
Outcome Assessment, Health Care
Patient Selection
Propensity Score
Registries
Retrospective Studies
Stroke
/ diagnostic imaging
Thrombolytic Therapy
Tomography, X-Ray Computed
CT
alteplase
outcome
safety
thrombolysis
wake‐up stroke
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
18 02 2020
18 02 2020
Historique:
entrez:
19
2
2020
pubmed:
19
2
2020
medline:
16
3
2021
Statut:
ppublish
Résumé
Background Intravenous thrombolysis (IVT) in wake-up stroke (WUS) or stroke with unknown onset (SUO) has been recently proven to be safe and effective using advanced neuroimaging (magnetic resonance imaging or computerized tomography-perfusion) for patient selection. However, in most of the thrombolyzing centers advanced neuroimaging is not instantly available. We hypothesize that pragmatic non-contrast computed tomography-based IVT in WUS/SUO may be feasible and safe. Methods and Results TRUST-CT (Thrombolysis in Stroke With Unknown Onset Based on Non-Contrast Computerized Tomography) is an international multicenter registry-based study. WUS/SUO patients undergoing non-contrast computed tomography-based IVT with National Institute of Health Stroke Scale ≥4 and initial Alberta Stroke Program Early Computerized Tomography score ≥7 were included and compared with propensity score matched non-thrombolyzed WUS/SUO controls. Primary end point was the incidence of symptomatic intracranial hemorrhage; secondary end points included 24-hour National Institute of Health Stroke Scale improvement of ≥4 and modified Rankin Scale at 90 days. One hundred and seventeen WUS/SUO patients treated with non-contrast computed tomography-based IVT were included. As compared with 112 controls, the median admission National Institute of Health Stroke Scale was 10 and the median Alberta Stroke Program Early Computerized Tomography score was 10 in both groups. Four (3.4%) IVT patients and one control patient (0.9%) suffered symptomatic intracranial hemorrhage (adjusted odds ratio 7.9, 95% CI 0.65-96,
Identifiants
pubmed: 32067594
doi: 10.1161/JAHA.119.014265
pmc: PMC7070213
doi:
Banques de données
ClinicalTrials.gov
['NCT03634748']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e014265Références
Stroke. 1989 Apr;20(4):473-6
pubmed: 2648651
N Engl J Med. 2019 May 9;380(19):1795-1803
pubmed: 31067369
Stroke. 2010 Nov;41(11):2491-8
pubmed: 20930152
Acta Neurol Scand. 2017 Jul;136(1):4-10
pubmed: 27641907
Neurology. 2010 Jan 12;74(2):136-41
pubmed: 20065248
Lancet. 2000 May 13;355(9216):1670-4
pubmed: 10905241
Ann Neurol. 2016 Aug;80(2):211-8
pubmed: 27273860
Wien Med Wochenschr. 2008;158(15-16):407-8, 408-10
pubmed: 18766308
N Engl J Med. 1995 Dec 14;333(24):1581-7
pubmed: 7477192
Eur J Neurol. 2019 May;26(5):754-759
pubmed: 30565361
Cerebrovasc Dis. 2010;29(4):336-42
pubmed: 20130399
Lancet. 2010 May 15;375(9727):1695-703
pubmed: 20472172
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Cerebrovasc Dis. 2003;16(2):128-33
pubmed: 12792170
eNeurologicalSci. 2019 Feb 05;14:91-97
pubmed: 30828649
PLoS One. 2018 May 22;13(5):e0197714
pubmed: 29787575
Stroke. 2002 Apr;33(4):988-93
pubmed: 11935049
Stroke. 1998 May;29(5):992-6
pubmed: 9596248
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Ann Neurol. 1992 Jul;32(1):78-86
pubmed: 1642475
J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2603-2609
pubmed: 27476340
J Am Heart Assoc. 2020 Feb 18;9(4):e014265
pubmed: 32067594